Neutrophil Transepithelial Migration and Epithelial Barrier Function in IBD
Potential Targets for Inhibiting Neutrophil Trafficking
ALEX C. CHIN,
CHARLES A. PARKOS,
ALEX C. CHIN
Epithelial Pathobiology Unit, Department of Pathology and Laboratory Medicine, Emory University Atlanta, Georgia 30322, USA
Search for more papers by this authorCHARLES A. PARKOS
Epithelial Pathobiology Unit, Department of Pathology and Laboratory Medicine, Emory University Atlanta, Georgia 30322, USA
Search for more papers by this authorALEX C. CHIN,
CHARLES A. PARKOS,
ALEX C. CHIN
Epithelial Pathobiology Unit, Department of Pathology and Laboratory Medicine, Emory University Atlanta, Georgia 30322, USA
Search for more papers by this authorCHARLES A. PARKOS
Epithelial Pathobiology Unit, Department of Pathology and Laboratory Medicine, Emory University Atlanta, Georgia 30322, USA
Search for more papers by this authorAddress for correspondence: Charles A. Parkos, M.D., Ph.D., Department of Pathology and Laboratory Medicine, Emory University, 615 Michael Street, Atlanta, GA, USA 30322. Voice: 404-727-8533; fax: 404-727-8538. e-mail: [email protected]
Abstract
Abstract: Neutrophil (PMN) transmigration across mucosal epithelia is a hallmark of inflammatory conditions, such as ulcerative colitis and Crohn's disease. PMN accumulation within epithelial crypts and in the intestinal lumen directly correlates with clinical disease activity and epithelial injury. Currently, the mechanisms by which PMNs migrate across mucosal epithelia are incompletely understood and a better understanding of this process will likely provide new insights into novel treatment strategies for inflammatory bowel disease. In this article, we discuss current advances that define PMN transepithelial migration, specifically focusing on PMN–epithelial adhesive interactions and signaling events. We also describe how these interactions might be specifically targeted for the development of therapeutic strategies to manage mucosal inflammation.
REFERENCES
- 1
Loftus, E.V. Jr. &
W.J. Sandborn. 2002. Epidemiology of inflammatory bowel disease.
Gastroenterol. Clin. North Am.
31: 1–20.
- 2
Irvine, E.J. &
J.K. Marshall. 2000. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk.
Gastroenterology
119: 1740–1744.
- 3
Schmitz, H.
et al
. 1999. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis.
Gastroenterology
116: 301–309.
- 4
Kumar, N.B.,
T.T. Nostrant &
H.D. Appelman. 1982. The histopathologic spectrum of acute self-limited colitis (acute infectious-type colitis).
Am. J. Surg. Pathol.
6: 523–529.
- 5
Kucharzik, T.
et al
. 2005. Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury.
Gut
54: 1565–1572.
- 6
Nash, S.,
J. Stafford &
J.L. Madara. 1987. Effects of polymorphonuclear leukocyte transmigration on barrier function of cultured intestinal epithelial monolayers.
J. Clin. Invest.
80: 1104–1113.
- 7
Parkos, C.A.
et al
. 1991. Neutrophil migration across a cultured intestinal epithelium: dependence on a CD1lb/CD18-mediated event and enhanced efficiency in the physiologic direction.
J. Clin. Invest.
88: 1605–1612.
- 8
Parkos, C.A.,
S.P. Colgan &
J.L. Madara. 1994. Interactions of neutrophils with epithelial cells: lessons from the intestine.
J. Am. Soc. Nephrol.
5: 138–152.
- 9
Nusrat, A.
et al
. 1997. Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair.
Gastroenterology
113: 1489–1500.
- 10
Edens, H.A.
et al
. 2002. Neutrophil transepithelial migration: evidence for sequential, contact-dependent signaling events and enhanced paracellular permeability independent of transjunctional migration.
J. Immunol.
169: 476–486.
- 11
Parsons, P.E.
et al
. 1987. The effect of neutrophil migration and prolonged neutrophil contact on epithelial permeability.
Am. J. Pathol.
129: 302–312.
- 12
Colgan, S.P.
et al
. 1995. Receptors involved in carbohydrate binding modulate intestinal epithelial-neutrophil interactions.
J. Biol. Chem.
270: 10531–10539.
- 13
Zen, K.
et al
. 2002. CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans.
J. Immunol.
169: 5270–5278.
- 14
Martin-Padura, I.
et al
. 1998. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration.
J. Cell. Biol.
142: 117–127.
- 15
Del Maschio, A.
et al
. 1999. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM).
J. Exp. Med.
190: 1351–1356.
- 16
Johnson-Leger, C.A.
et al
. 2002. Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration.
Blood
100: 2479–2486.
- 17
Ostermann, G.
et al
. 2002. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes.
Nat. Immunol.
3: 151–158.
- 18
Zen, K.
et al
. 2004. JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration.
Mol. Biol. Cell.
15: 3926–3937.
- 19
Zen, K.
et al
. 2005. Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils.
Mol. Biol. Cell.
16: 2694–2703.
- 20
Bazzoni, G.
2003. The JAM family of junctional adhesion molecules.
Curr. Opin. Cell. Biol.
15: 525–530.
- 21
Moog-Lutz, C.
et al
. 2003. JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells.
Blood
102: 3371–3378.
- 22
Liu, Y.
et al
. 2000. Human junction adhesion molecule regulates tight junction resealing in epithelia.
J. Cell. Sci.
113(
Pt 13
): 2363–2374.
- 23
Bazzoni, G.
et al
. 2005. Expression of junctional adhesion molecule-A prevents spontaneous and random motility.
J. Cell. Sci.
118: 623–632.
- 24
Khandoga, A.
et al
. 2005. Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration.
Blood
106: 725–733.
- 25
Corada, M.
et al
. 2005. Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia–reperfusion injury.
Proc. Natl. Acad. Sci. USA
102: 10634–10639.
- 26
Shaw, S.K.
et al
. 2001. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma does not reduce leukocyte transmigration under flow.
Am. J. Pathol.
159: 2281–2291.
- 27
Bazzoni, G.
et al
. 2000. Homophilic interaction of junctional adhesion molecule.
J. Biol. Chem.
275: 30970–30976.
- 28
Mandell, K.J.,
I.C. McCall &
C.A. Parkos. 2004. Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function.
J. Biol. Chem.
279: 16254–16262.
- 29
Mandell, K.J.
et al
. 2005. Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity.
J. Biol. Chem.
280: 11665–11674.
- 30
Martinez-Estrada, O.M.
et al
. 2001. Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells.
J. Biol. Chem.
276: 9291–9296.
- 31
Santoso, S.
et al
. 2002. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1.
J. Exp. Med.
196: 679–691.
- 32
Aurrand-Lions, M.
et al
. 2005. Junctional adhesion molecule-C regulates the early influx of leukocytes into tissues during inflammation.
J. Immunol.
174: 6406–6415.
- 33
Dorner, A.A.
et al
. 2005. Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development.
J. Cell. Sci.
118: 3509–3521.
- 34
Reinhold, M.I.
et al
. 1995. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47).
J. Cell. Sci.
108(
Pt 11
): 3419–3425.
- 35
Cooper, D.
et al
. 1995. Transendothelial migration of neutrophils involves integrin-associated protein (CD47).
Proc. Natl. Acad. Sci. USA
92: 3978–3982.
- 36
Parkos, C.A.
et al
. 1996. CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia.
J. Cell. Biol.
132: 437–450.
- 37
Liu, Y.
et al
. 2001. The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47.
J. Biol. Chem.
276: 40156–40166.
- 38
Brown, E.J. &
W.A. Frazier. 2001. Integrin-associated protein (CD47) and its ligands.
Trends Cell. Biol.
11: 130–135.
- 39
Liu, Y.
et al
. 2002. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
J. Biol. Chem.
277: 10028–10036.
- 40
Liu, Y.
et al
. 2005. SIRPbeta 1 is expressed as a disulfide-linked homodimer in leukocytes and positively regulates neutrophil transepithelial migration.
J. Biol. Chem.
280: 36132–36140.
- 41
Liu, Y.
et al
. 2004. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha.
J. Immunol.
172: 2578–2585.
- 42
Colgan, S.P.
et al
. 1993. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers.
J. Clin. Invest.
92: 75–82.
- 43
Strohmeier, G.R.
et al
. 1997. Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia.
J. Clin. Invest.
99: 2588–2601.
- 44
Halstensen, T.S.
et al
. 1990. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis.
Gastroenterology
98: 1264–1271.
- 45
Reaves, T.A.
et al
. 2001. Neutrophil transepithelial migration: regulation at the apical epithelial surface by Fc-mediated events.
Am. J. Physiol. Gastrointest. Liver Physiol.
280: G746–G754.
- 46
Parkos, C.A.
et al
. 1996. Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils.
Mol. Med.
2: 489–505.
- 47
Huang, G.T.
et al
. 1996. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion.
J. Clin. Invest.
98: 572–583.
- 48
King, P.D.
et al
. 1990. The role of CD44, CD45, CD45RO, CD46 and CD55 as potential anti-adhesion molecules involved in the binding of human tonsillar T cells to phorbol 12-myristate 13-acetate-differentiated U-937 cells.
Eur. J. Immunol.
20: 363–368.
- 49
Lawrence, D.W.
et al
. 2003. Antiadhesive role of apical decay-accelerating factor (CD55) in human neutrophil transmigration across mucosal epithelia.
J. Exp. Med.
198: 999–1010.
- 50
Hamann, J.
et al
. 1996. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
J. Exp. Med.
184: 1185–1189.
- 51
Hamann, J.
et al
. 1998. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97.
Eur. J. Immunol.
28: 1701–1707.
- 52
Qian, Y.M.
et al
. 1999. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
Immunology
98: 303–311.
- 53
Lea, S.
2002. Interactions of CD55 with non-complement ligands.
Biochem. Soc. Trans.
30: 1014–1019.
